MT Genex Balance Sheet Health
Financial Health criteria checks 5/6
MT Genex has a total shareholder equity of ¥3.9B and total debt of ¥145.0M, which brings its debt-to-equity ratio to 3.7%. Its total assets and total liabilities are ¥4.8B and ¥898.0M respectively. MT Genex's EBIT is ¥506.0M making its interest coverage ratio -50.6. It has cash and short-term investments of ¥1.9B.
Key information
3.7%
Debt to equity ratio
JP¥145.00m
Debt
| Interest coverage ratio | -50.6x |
| Cash | JP¥1.93b |
| Equity | JP¥3.88b |
| Total liabilities | JP¥898.00m |
| Total assets | JP¥4.78b |
Recent financial health updates
No updates
Recent updates
Why Investors Shouldn't Be Surprised By MT Genex Corporation's (TSE:9820) Low P/E
Mar 08
MT Genex (TYO:9820) Has More To Do To Multiply In Value Going Forward
Apr 28You Have To Love MT Genex Corporation's (TYO:9820) Dividend
Mar 17Are Strong Financial Prospects The Force That Is Driving The Momentum In MT Genex Corporation's TYO:9820) Stock?
Feb 11Will MT Genex's (TYO:9820) Growth In ROCE Persist?
Dec 31Is MT Genex Corporation (TYO:9820) A Smart Pick For Income Investors?
Nov 18
Financial Position Analysis
Short Term Liabilities: 9820's short term assets (¥4.3B) exceed its short term liabilities (¥549.0M).
Long Term Liabilities: 9820's short term assets (¥4.3B) exceed its long term liabilities (¥349.0M).
Debt to Equity History and Analysis
Debt Level: 9820 has more cash than its total debt.
Reducing Debt: 9820's debt to equity ratio has increased from 0% to 3.7% over the past 5 years.
Debt Coverage: 9820's debt is well covered by operating cash flow (259.3%).
Interest Coverage: 9820 earns more interest than it pays, so coverage of interest payments is not a concern.